Diabetes
Cholesterol
Obesity
Dyslipidemia
Hypertension
Insulin Resistance
Poly Cystic Ovarian    Syndrome (PCOS)
Metabolism
Preventing CVD
Fatty Liver Disease
More Articles
DISCLAIMER
Metabolic Institute of America
The Metabolic Institute of America was founded as an answer to the growing global epidemic of obesity and multiple metabolic disorders. It is dedicated to clinical research and the education of diabetes, hypertension, lipid disorders, obesity and related metabolic disorders, in order to prevent cardiovascular disease and other associated complications. The MIA's mission is to advance the understanding and management of metabolic diseases.

Read about the institute staff

The Metabolic Institute of America is inviting patients to participate in a clinical research study related to the endocrine and metabolic fields, which focuses on treatments for diabetes mellitis, cholesterol & lipid abnormalities and high blood pressure. Participating in a study will allow you to control a medical condition better, while becoming an important part of medical science and its development.

To Participate in a Clinical Study Click Here

  
Yehuda Handelsman MD, FACP, FACE, FNLA is the Medical Director of the Metabolic Institute of America. He is an endocrinologist in solo private practice in Tarzana, California, where he developed and successfully utilized a unique, multiple-intervention approach to preventing cardiovascular disease in the high risk patient.

Read More about Yehuda Handelsman
The Medical Education Management (MEM) division creates educational initiatives, and assists in the development of programs by others. It provides administrative services to national and international medical conferences and associations, and interacts with the health media and lay associations to develop educational health programs for the public.
Read More
 
  
Developing state of the art technique. Providing superior medical evaluation and treatment for patients with medical conditions. Predicting and preventing cardiovascular disease and diabetes in persons with obesity, HTM, lipid disorders, insulin resistance, and its complications like PCOS and fatty liver disease.